Stock Preacher

SciClone Pharmaceuticals Inc. (NASDAQ: SCLN)

SciClone Pharmaceuticals Inc. (SCLN) is a global biopharmaceutical company engaged in the development and commercialization of therapeutics for the treatment of cancer and infectious diseases. The Company’s primary product is ZADAXIN, its own brand of thymalfasin or thymosin alpha 1, and is sold in more than 30 countries for the treatment of hepatitis B (HBV) and hepatitis C (HCV), certain cancers and as a vaccine adjuvant. SCLN develops a pipeline of phase 2 and 3 drug candidates, which includes thymalfasin for stage IV melanoma, RP101 for the treatment of pancreatic cancer, and SCV-07 for the delay of the onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of HCV. In China, the Company is pursuing regulatory approval for DC Bead™ as an embolic agent for the treatment of liver cancer. Read more

Popularity: unranked [?]

A visiting Chinese business delegation sealed deals amounting to 2 billion U.S. dollars with British firms in London on Friday afternoon in a significant move to stave off protectionism in the wake of the global financial crisis. The agreement between Hainan Airlines Co. Ltd and Rolls-Royce Plc was the largest deal totaling 1.2 billion dollars.

Rolls-Royce is to provide 20 engines for the Airbus 330 of the Hong Kong fleet, in addition to a 15-year service support. The 11 procurement deals and agreements covered areas ranging from textile, metal services, airplane and automobile parts, pharmaceutical, new materials, eco-town building, and motion picture production.

Chen Deming, China’s commerce minister who led a 150-strong delegation of government officials and entrepreneurs, said at a China-UK business symposium on trade and economic cooperation that the trip is aimed at boosting bilateral business confidence amid the current economic downturn. According the Chen, trade between China and Britain dropped 2.6 percent in January this year, a clear sign of the global economic recession.

However, he believed that Chinese businesses would like to take advantage of the British strength in research and development, high technology, even retail and textile to find ways for collaboration. “This is just a beginning of our trade ties this year. A further group of Chinese businesses will come to Britain in a week’s time to explore trade and investment opportunities,” said the minister.

Popularity: 6% [?]